13. Drugs for Cardiac Arrhythmias, Antithrombotic Drugs and Lipid Modulating Drugs

Sheila A Doggrell

Discipline of Medical Sciences, Faculty of Science and Technology, Queensland University of Technology, Gardens Point, GPO Box 2434, QLD 4001, Australia

Phone +61 7 38705741 Fax +61 7 31381534 Email sheila.doggrell@qut.edu.au

Reviewer required

Key words: cardiac arrhythmia, cardiac action potential, Class I-IV, lignocaine, esmolol, d-sotalol, verapamil, amiodarone, adenosine, antithrombotic, antiplatelet drugs, aspirin, clopidogrel, abciximab, anticoagulants, heparin, enoxaparin, warfarin, dabigatran, fondaparinux, fibrinolytics, streptokinase, alteplase, lipid-modulating drugs, simvastatin, gemfibrozil, ezetimibe

Contents

13.1 Drugs for cardiac arrhythmias

13.1.1 Introduction to cardiac arrhythmias

13.1.2 Cardiac action potentials

13.1.3 Mechanisms of cardiac arrhythmias

13.1.3 Class I

13.1.4 Class II

13.1.5 Class III

12.1.6 Class IV

13.1.7 Amiodarone

13.1.8 Adenosine

13.2 Antithrombotic drugs

13.2.1 Thrombus formation

13.2.2 Platelet aggregation and anti-platelet drugs

13.2.3 Coagulation

13.2.4 Anticoagulants

13.2.5 Fibrinolysis and fibrinolytics

13.3. Lipid modulating drugs

13.3.1 Cholesterol

13.3.2 Statins

13.3.3 Fibric acid derivatives

13.3.4 Ezetimibe

Drugs for cardiac arrhythmias, antithrombotic drugs and lipid modify drugs are considered in this section.